Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunomodulatory Therapy to Restore Ovarian Function and Improve Fertility in Women With Autoimmune Premature Ovarian Insufficiency - Double-blind, Placebo-contrelled, Randomized Study.

NCT07509840 is registered in ClinicalTrials.gov with Angelica Lindén Hirschberg as lead sponsor.

NCT NCT07509840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07509840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunomodulatory Therapy to Restore Ovarian Function and Improve Fertility in Women With Autoimmune Premature Ovarian Insufficiency - Double-blind, Placebo-contrelled, Randomized Study.
Lead sponsor
Angelica Lindén Hirschberg
Phase
Phase 3
Overall status
Recruiting
Start date
February 12, 2026
Completion date
December 31, 2031
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune prematur ovarian insuffience